BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3827423)

  • 41. HLA-A, B, C antigens in pulmonary sarcoidosis in Polish population.
    Dubaniewicz A; Szczerkowska Z
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):55-9. PubMed ID: 11729830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA antigens in Turkish race with rheumatic heart disease [see comment].
    Ozkan M; Carin M; Sönmez G; Senocak M; Ozdemir M; Yakut C
    Circulation; 1993 Jun; 87(6):1974-8. PubMed ID: 8504512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis.
    Foley PJ; Lympany PA; Puscinska E; Zielinski J; Welsh KI; du Bois RM
    Am J Respir Crit Care Med; 1999 Sep; 160(3):1009-14. PubMed ID: 10471632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignant bone and soft-tissue tumor and HLA.
    Wong AC
    Nihon Seikeigeka Gakkai Zasshi; 1985 Jul; 59(7):719-33. PubMed ID: 3864905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Genetic background of sarcoidosis--special reference to HLA].
    Yamaguchi E; Kawakami Y
    Nihon Rinsho; 2002 Sep; 60(9):1679-87. PubMed ID: 12233061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical features of sarcoidosis in relation to HLA distribution and HLA-DRB3 genotyping by PCR-RFLP.
    Ishihara M; Ishida T; Mizuki N; Inoko H; Ando H; Ohno S
    Br J Ophthalmol; 1995 Apr; 79(4):322-5. PubMed ID: 7742275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA-G polymorphisms and HLA-G expression in sarcoidosis.
    Hviid TV; Milman N; Hylenius S; Jakobsen K; Jensen MS; Larsen LG
    Sarcoidosis Vasc Diffuse Lung Dis; 2006 Mar; 23(1):30-7. PubMed ID: 16933468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?
    Peano G; Menardi G; Ponzetto A; Fenoglio LM
    Arch Intern Med; 1994 Dec 12-26; 154(23):2733-6. PubMed ID: 7993158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD8 alveolitis in sarcoidosis: incidence, phenotypic characteristics, and clinical features.
    Agostini C; Trentin L; Zambello R; Bulian P; Siviero F; Masciarelli M; Festi G; Cipriani A; Semenzato G
    Am J Med; 1993 Nov; 95(5):466-72. PubMed ID: 8238062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HLA typing in an IFN-alpha-induced scar sarcoidosis: possible pathogenetic and clinical implications.
    Zampino MR; Corazza M; Borghi A; Marzola A; Virgili A
    Acta Derm Venereol; 2009 Nov; 89(6):661-2. PubMed ID: 19997710
    [No Abstract]   [Full Text] [Related]  

  • 51. [Sarcoidosis in a man and his identical twin sons].
    Nakamura H; Hashimoto T; Yagyuu H; Sudou A; Sarashina G; Hatao E; Tuchida F; Adachi H; Kishi K; Kashiwabara K; Matsuoka T
    Nihon Kokyuki Gakkai Zasshi; 2000 Jun; 38(6):452-5. PubMed ID: 10979283
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histologic findings in siblings with acute sarcoid arthritis: association with the B8,DR3 phenotype.
    Kremer JM
    J Rheumatol; 1986 Jun; 13(3):593-7. PubMed ID: 3488404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA-A, B, C, DR, MT, and MB antigens in recurrent aphthous stomatitis.
    Gallina G; Cumbo V; Messina P; Caruso C
    Oral Surg Oral Med Oral Pathol; 1985 Apr; 59(4):364-70. PubMed ID: 3873635
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis.
    Foley PJ; McGrath DS; Puscinska E; Petrek M; Kolek V; Drabek J; Lympany PA; Pantelidis P; Welsh KI; Zielinski J; du Bois RM
    Am J Respir Cell Mol Biol; 2001 Sep; 25(3):272-7. PubMed ID: 11588003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Familial occurrence of sarcoidosis and Crohn's disease.
    Grönhagen-Riska C; Fyhrquist F; Hortling L; Koskimies S
    Lancet; 1983 Jun; 1(8336):1287-8. PubMed ID: 6134089
    [No Abstract]   [Full Text] [Related]  

  • 56. Differences in the distribution of HLA antigens in localized and generalized form of onchocerciasis.
    Brattig NW; Tischendorf FW; Reifegerste S; Albiez EJ; Berger J
    Trop Med Parasitol; 1986 Sep; 37(3):271-5. PubMed ID: 3466335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [HLA typing in high risk keratoplasty].
    Hirsch N; Nölle B; Zavazava N; Westphal E; Duncker G; Rochels R; Müller-Ruchholtz W
    Ophthalmologe; 1993 Apr; 90(2):174-7. PubMed ID: 8490302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Analysis of occurrence of DRB and DQ alleles in sarcoidosis and tuberculosis from Northern Poland].
    Dubaniewicz A; Moszkowska G
    Pneumonol Alergol Pol; 2007; 75(1):13-21. PubMed ID: 17541908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The treatment, course and prognosis of sarcoidosis cases].
    Takada K; Ina Y; Noda M; Morishita M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):92-9. PubMed ID: 2355691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients.
    Grunewald J; Eklund A; Olerup O
    Am J Respir Crit Care Med; 2004 Mar; 169(6):696-702. PubMed ID: 14656748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.